lobbying_activities: 2596325
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2596325 | 0683667d-8c1b-4b48-bf61-8f2dff90561e | Q1 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | GLENMARK PHARMACEUTICALS, INC., USA | 2021 | first_quarter | PHA | Issues related to H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-15T14:00:18.890000-04:00 |